Yiheng Capital Lowers stake in Synutra International (SYUT)

Synutra International (SYUT) : Yiheng Capital reduced its stake in Synutra International by 9.21% during the most recent quarter end. The investment management company now holds a total of 406,178 shares of Synutra International which is valued at $1.7 Million after selling 41,216 shares in Synutra International , the firm said in a disclosure report filed with the SEC on May 13, 2016.Synutra International makes up approximately 1.17% of Yiheng Capital’s portfolio.

Other Hedge Funds, Including , Renaissance Technologies reduced its stake in SYUT by selling 33,100 shares or 29.53% in the most recent quarter. The Hedge Fund company now holds 79,000 shares of SYUT which is valued at $338,910. Gsa Capital Partners Llp sold out all of its stake in SYUT during the most recent quarter. The investment firm sold 17,347 shares of SYUT which is valued $74,419.

Synutra International opened for trading at $4.12 and hit $4.16 on the upside on Wednesday, eventually ending the session at $4.15, with a gain of 0.24% or 0.01 points. The heightened volatility saw the trading volume jump to 33,943 shares. Company has a market cap of $236 M.

Synutra International Inc. is an infant formula company in China. The Company is engaged in the production distribution and sale of dairy-based nutritional products under the Shengyuan or Synutra line of brands. The Company operates through three segments: Nutritional Food which includes the sale of powdered infant and adult formula products with brands including Super My Angel and Dutch Cow as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement which includes the production and sale of nutritional supplements such as chondroitin sulfate to third-parties and microencapsulated Docosahexanoic Acid and Arachidonic Acid to the nutritional food segment for use in powdered formula production and Other Business which includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers providing genetic diagnostic services for new born babies and sales of cosmetics to pregnant women.

Leave a Reply

Synutra International - Is it time to Sell?

Top Brokerage Firms are advising their investors on Synutra International. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.